Platelet‐to‐lymphocyte ratio predicts the prognosis of patients with non‐small cell lung cancer treated with surgery and postoperative adjuvant chemotherapy

BACKGROUND: Markers of preoperative tumor immunity, such as platelet‐to‐lymphocyte ratio (PLR), have been reported to be prognostic factors for patients with various cancers. However, the relationship between PLR and the prognosis of non‐small cell lung cancer (NSCLC) patients treated with surgery a...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Thorac Cancer
Prif Awduron: Toda, Michihito, Tsukioka, Takuma, Izumi, Nobuhiro, Komatsu, Hiroaki, Okada, Satoshi, Hara, Kantaro, Miyamoto, Hikaru, Ito, Ryuichi, Shibata, Toshihiko, Nishiyama, Noritoshi
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: John Wiley & Sons Australia, Ltd 2017
Pynciau:
Original Articles
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5754286/
https://ncbi.nlm.nih.gov/pubmed/29105365
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.12547
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg